FIGURE

Fig. 3

ID

ZDB-FIG-140114-51

Publication

Jayasena et al., 2012 - Rbms3 functions in craniofacial development by posttranscriptionally modulating TGF-β signaling

Other Figures

All Figure Page

Back to All Figure Page

Fig. 3

Craniofacial defects in rbms3 morphants. (A) rbms3 MO design (E2, exon 2; I2, intron 2). Atg MO treatment results in knockdown of Citrine-Rbms3 (middle). Sp MO results in skipping of exon 3 (red arrow), and some transcripts maintain a portion of intron 3 (i3, yellow, black arrow), resulting in truncated Rbms3 products. The Sp MO also generates other minor splice variants (black arrowheads). (B) Atg morphants (boxed larvae) show craniofacial defects. (C) Alcian blue cartilage staining in Atg MO–treated fish. Top row, lateral view; bottom row, ventral view. (D) Quantification of cartilage phenotype for Sp and Atg MOs. (E) Full-length rbms3 partially/fully rescues Atg MO severe phenotype (**, P < 0.001, Χ² test). n = total number of treated fish from 3–4 experiments (D and E). Error bars indicate SD. Bars, 200 µM.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Fish:	AB + MO1-rbms3
Knockdown Reagent:	MO1-rbms3
Observed In:	chondrocranium cartilage embryonic neurocranium morphogenesis embryonic viscerocranium morphogenesis head heart pharyngeal arch cartilage
Stage Range:	Protruding-mouth to Day 4

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image.

Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/ ).

Full text @ J. Cell Biol.